Skip to main content
Home > Field of Cooperation > Health Research > Antigenicity to humans and gene polymorphism of the new malaria vaccine candidate, TAM (Trans-amidase like molecule) of Asian malaria
Antigenicity to humans and gene polymorphism of the new malaria vaccine candidate, TAM (Trans-amidase like molecule) of Asian malaria
Principal Investigator / Affiliation Prof. Kenji Hirayama / Institute of Tropical Medicine (NEKKEN), Nagasaki University flag Japan Japan
Director, Prof.Tin Maung Hlaing / Defense Services Medical Research Center flag Myanmar Myanmar
Department Chair, Prof. Mario Jiz / Immunology Department, Research Institute for Tropical Medicine (RITM) flag Philippines Philippines
Approved Fiscal Year 2015
Research Period 3 years
General Description of the Research Project This collaborative research aims to produce a malaria vaccine that is useful for the control of Asian malaria by combining Japanese research and development ability with field research capacity in the Philippines and Myanmar.
Photo Gallery  
Reports  
Links